Public, NASDAQ:PARD
NASDAQ Global Market
Poniard Pharmaceuticals Appoints Janet R. Rea to Vice President, Regulatory Affairs and Quality
Date: Thu, 10 Jul 2008 23:29:31 GMT
Tags:
Poniard Pharmaceuticals Appoints Janet R. Rea to Vice President, Regulatory Affairs and Quality
RedOrbit - Jul 10, 2008
RedOrbit - Jul 10, 2008
SOUTH SAN FRANCISCO , Calif . , July 10 / PRNewswire - FirstCall / - - Poniard Pharmaceuticals , Inc . , a biopharmaceutical company focused on oncology , today announced that it has appointed ...
Poniard Pharmaceuticals Appoints Janet R. Rea to Vice President, Regulatory Affairs and Quality
Date: Thu, 10 Jul 2008 12:17:47 GMT
Tags:
Poniard Pharmaceuticals Appoints Janet R. Rea to Vice President, Regulatory Affairs and Quality
Earthtimes (press release) - Jul 10, 2008
Earthtimes (press release) - Jul 10, 2008
SOUTH SAN FRANCISCO , Calif . , July 10 - - Poniard Pharmaceuticals , Inc . ( Nasdaq : PARD ) , a biopharmaceutical company focused on oncology , today announced that it has appointed Janet R ...
2008-07-04 20:39:18 - www.companiesandmarkets.com adds new report - Poniard Pharmaceuticals Inc - Premium Company Profile
Date: Fri, 04 Jul 2008 19:00:43 GMT
Tags:
2008-07-04 20:39:18 - www.companiesandmarkets.com adds new report - Poniard Pharmaceuticals Inc - Premium Company Profile
PR-Inside.com (Pressemitteilung) - Jul 4, 2008
PR-Inside.com (Pressemitteilung) - Jul 4, 2008
Poniard Pharmaceuticals , formerly known as NeoRx Corporation , is a biopharmaceutical company focused on the discovery , development and commercialization of cancer therapy products.The company ...
Poniard Pharmaceuticals to Present at the 7th Annual Needham Biotechnology and Medical Technology Conference
Date: Thu, 05 Jun 2008 12:28:56 GMT
Tags:
Poniard Pharmaceuticals to Present at the 7th Annual Needham Biotechnology and Medical Technology Conference
PR Newswire (press release) - Jun 5, 2008
PR Newswire (press release) - Jun 5, 2008
- Company to Present Recent Clinical Data Highlights from ASCO and Corporate Update - SOUTH SAN FRANCISCO , Calif . , June 5 / PRNewswire - FirstCall / - - Poniard Pharmaceuticals , Inc . ( Nasdaq ...
Market Report -- In Play (WIRES)
Date: Mon, 02 Jun 2008 06:33:50 GMT
Tags:
Market Report -- In Play (WIRES)
MSN Money - Jun 2, 2008
MSN Money - Jun 2, 2008
On The Wires Poniard Pharmaceuticals ( PARD ) announces safety and efficacy results from a previously unpublished Phase 1 clinical trial of picoplatin and liposomal doxorubicin in patients with ...
Poniard Pharmaceuticals Appoints Janet R. Rea to Vice President, Regulatory Affairs and Quality (PR Newswire)
Date: Thu, 10 Jul 2008 12:00:00 Etc/GMT
Tags:
Poniard Pharmaceuticals, Inc. , a biopharmaceutical company focused on oncology, today announced that it has appointed Janet R. Rea, MSPH, RAC, as vice president, regulatory affairs and quality.
Russell 2000 adds 53 health care companies (AP)
Date: Mon, 30 Jun 2008 18:16:09 Etc/GMT
Tags:
More than 50 companies in the health care sector were added to the Russell 2000 in this year's reconstitution of the small stock index, while 30 companies in the sector were removed from the index.
Poniard Pharmaceuticals: Platinum Rediscovered (Part II) (at Seeking Alpha)
Date: Tue, 24 Jun 2008 15:20:31 Etc/GMT
Tags:
Poniard Pharmaceuticals to Present at the 7th Annual Needham Biotechnology and Medical Technology Conference (PR Newswire)
Date: Thu, 5 Jun 2008 12:00:00 Etc/GMT
Tags:
Poniard Pharmaceuticals, Inc. , a biopharmaceutical company focused on oncology, today announced that Jerry McMahon, Ph.D., chairman and CEO, will present at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference on Wednesday, June 11, at 9:00 a.m.
PONIARD PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)
Date: Thu, 5 Jun 2008 10:02:06 Etc/GMT
Tags: